Dixie Brands subsidiary receives patent for breakthrough in cannabinoid delivery

Monday December 9, 2019 0 comments Tags: Denver, Dixie Brands, Chuck Smith, Aceso Wellness

DENVER -- Dixie Brands Inc. (CSE: DIXI.U), (OTCQX: DXBRF), (Frankfurt: 0QV) today announced the U.S. Patent and Trademark Office will issue its wholly-owned subsidiary, Aceso Wellness, LLC ("Aceso"), a patent for a unique range of formats providing for the delivery of cannabinoids, along with nutrients, in effervescent powder and/or aqueous liquid forms.Dixie-Brands-logo 

The patent application, entitled 'Cannabinoid Emulsion Product and Process for Making the Same', encompasses a broad set of popular formats and formulations that provide for various nutraceutical compositions including cannabinoids, supplements and vitamins, Dixie Brands said.

These compositions have been configured for specific uses such as the promotion of the immune system, improved energy levels, joint and bone health, reduced inflammation, and more efficient cellular energy metabolism.

"This patent is the culmination of a 3-year process and demonstrates our commitment to, and investment in, the potential power of the inclusion of cannabinoids to help support healthy lifestyles." said Jay Denniston, Dixie Brands director of science.

"It provides proven, efficacious formats for consumers as they continue to explore cannabis as a plant-based, healthy alternative to traditional pharmaceutical products."

Dixie Brands said its patented technology provides an extensive and protected platform to further access the burgeoning U.S. dietary supplement market in addition to the rapidly emerging hemp-derived category.

The U.S. dietary supplement market is expected to grow to nearly $57 billion by 2024 (Source: Matej Mikulic, Sep 19, 2019) lead by non-pill formats and fueled by increasing consumer awareness of nutrition, a focus on preventative health care and a desire for solutions that are perceived to be more natural.

"This is an incredibly exciting development for Dixie Brands, reflecting the depth of our R&D heritage, established over nearly a decade." said Chuck Smith, Dixie Brands president and CEO.

"As the FDA provides positive guidance and the category continues to grow, securing patents for our scientific intellectual property not only provides protection for key elements of our portfolio and optimizes shareholder value but also further supports the continued legitimization and normalization of the cannabis industry."

The patented technology has been commercialized by Aceso's range of hemp-derived sprays, dissolvable tablets and powder sachets.

The effervescent powder lies at the center of the company's growth strategy in the hemp-derived CBD market due to the existing popularity of that format in the broader health and wellness category.

The portfolio currently includes Calm, Soothe and Wellness variants and is available in more than 1,000 brick-and-mortar stores across the U.S.

The breadth of the forthcoming patent protects the inclusion of cannabinoids in products across a broader range of formats and channels including the regulated cannabis marketplace, the company said.